Essay On Adherence To Oral Antipsychotics

As the second decade of the 21st century progresses, the population approaches seven billion. With so many people, how are people supposed to stand out in job applications, or catch the administrators’ eye as he or she reads applications to highly prestigious colleges and universities? More and more people are asking this question, and more and more people are finding help in a small pill. Originally diagnosed for Alzheimer’s disease and ADHD, these drugs are increasingly used off label in universities and workplaces. In society, people call this form of off label use of neuroenhancing drugs chiefly two different things: smart drugs informally, and nootropics formally. The word nootropic originated from a Romanian Dr. Corneliu E.

Those opposing the use of CTO’s are influenced by three reasons to support their position. The first reason deals with the current evidence base. For starters, international research literature has found no strong evidence on the positive or negative effects of CTO’s on three key outcomes. These outcomes are “hospital readmissions, length of hospital stay, and ‘patients’ quality of life” (Lawton-Smith et al, 2008) Furthermore, a 36-month study of 198 “patients” concluded that CTO’s do not prevent relapse and readmission of psychiatric inmates with severe and enduring “mental illnesses”. The study showed that results were in line with the current national use (Rugkasa, Yeeles, Koshiaris, & Burns, 2016). Analysis of these results shows that there is no compelling reason for CTO’s to continue to exists, given the lack of improvement that they provide.

Special attention should be giving to understanding informed consent and any challenges that may be presented and prescribing ethically medications to special populations such as children. According to the Gerald Tietz of the Washington law review (1986), indicates that it is well within a practitioner’s scope of duty to inform the patient of significant effects were injuries that may be related to the prescribing of any particular pharmacological treatment. This informed consent should be expanded to include the harms were dangerous presented also with non-use of additional treatment interventions such as therapy or CBT. Additional trends identified in ambulance pediatrics (Cooper, Arbogast & Ding, 2006), or the trends and the prescription of antipsychotic medications for children in the United States of America. The information taken from the national ambulatory medical care survey in regards to the US population indicated that between 1995 and 2002 there were nearly 6,000,000 visits to health providers by children in the US that had been subscribed or prescribed antipsychotic medications. Nearly 1/3 of the prescriptions for lease populations were provided by non-mental health service professionals. The study of the department of pediatrics at Vanderbilt University in Nashville also indicated that over half of the prescriptions for these children were given based on behavioral indications or affective disorders which find a way

The provision of health care services being informed by principles of evidence-based care, integration and patient engagement has mixed outcomes for mental health care. Evidence-based care focuses heavily on psychopharmaceuticals compared to psychotherapy in terms of funding because it is easier to present results of different drugs (quantitative data) than to present results of therapy (ex. CBT → qualitative data).

For most individuals with schizophrenia, a thorough treatment plan is vital to assist with medication adherence, reduce hospitalization and to provide improvement in quality of life. Typically a prescription for antipsychotics is necessary not only to reduce positive

A research study was conducted by Dr. Helen Kales and others as to whether or not antipsychotic drugs increased mortality rate in elderly dementia patients. In her article in The American Journal of Psychiatry, Kales concluded, “Antipsychotic medications taken by patients with dementia were associated with higher mortality rates than were most other medications used for neuropsychiatric symptoms.” According to Dr. Lyketos, who did a presentation about dementia patients, “A few neuropsychiatric symptoms in dementia patients include: depression, sundowning, anxiety, repetitious questioning, and sleep disturbance” (Lyketos). Sundowning is one of the most common symptoms and occurs when the patient suffers “increased confusion and agitation at cyclic

Medication is an important treatment for individuals with schizophrenia disorder. Antipsychotics, mood stabilizers and antidepressants are the most popular for treating these individuals (Rubin, Springer, & Trawver, 2010). Because their treatment revolves around medication to help stabilize them, it is important to set up behavioral tailoring interventions. Behavioral tailoring involves cues that remind the individual to take their medication, usually paired with routines (Rubin, Springer, & Trawver, 2010). These routines could be anything from teeth rushing to brushing your hair, and involve set reminders to take the medication (Rubin, Springer, & Trawver, 2010). The adherence to taking the medication has a long-term improvement on their disorder (Rubin, Springer, & Trawver, 2010). Although this is only effective with

A widely known challenge chronic in healthcare is the readmission of a large percentage of patients who do not follow their medication regimen. The readmission is normally caused due to poor adherence to non-adherence. For the purpose of this week’s discussion this post will cover the definition of quality improvement (QI). QI is defined as the use of data to monitor the outcomes of care processes, improvement methods to design and test changes to continuously improve the quality and safety of health care systems (Hinkle, Cheever, & Kerry, 2014).

As we have seen, treatment of schizophrenia with antipsychotic drugs can have impressive results in terms of decreasing active symptoms, although it does nothing to alleviate negative symptoms or to improve cognitive functioning. Unfortunately, this kind of treatment has the drawback of extremely serious and even fatal side-effects. Newer generation atypical antipsychotics offer more hope, as they can treat both active and negative symptoms, and also improve cognitive functioning. Moreover, they have fewer side-effects. However, treatment is complicated by the fact that results are unpredictable; and in addition the side-effects that they do have can be very serious, such as diabetes, which in itself is life-threatening. However, as the potential side-effects are known, the physician has leeway to choose a drug which is a good match for the patient’s clinical profile. Then, once the patient’s symptoms have been much alleviated with an appropriate newer generation atypical antipsychotic, the patient should be able to also benefit from a range of psychotherapeutic interventions. It is argued that this is the best treatment regime to choose, as it is likely to result in the greatest improvement in quality of life, coupled with the lowest risk of potentially devastating side-effects, or of death. This is likely to be better than utilizing cognitive behavioral therapy, the results of which are not reliably known – although research has certainly shown that it is less efficacious

Antidepressants have a history of causing violent side effects, including suicide and homicide in those consuming the prescribed drugs. Many antidepressants that are prescribed to those with a mental illness come packaged with a warning label that reads: “New or worsening depression; thinking about harming or killing yourself, or planning or trying to do so; extreme worry; agitation; panic attacks; difficulty falling asleep or staying asleep; aggressive behavior; irritability; acting without thinking; severe restlessness; and frenzied abnormal excitement." This warning label is a most know for school officials who are aware of students dealing with a mental illness. Statistics show that five of the top 10 most violence-inducing drugs were found

Schizophrenia is a chronic brain disorder that affects more than one percent of the population. When schizophrenia is active, symptoms can include delusions, hallucinations, trouble with thinking and concentration, and lack of motivation. However, when these symptoms are treated properly, a large portion of those diagnosed will greatly improve over time.

I learnt that using anti-psychotics is just a component of a holistic approach to a patient with psychotic illness and that care should also include psychological treatments

Approximately 22% of the American population suffers from some kind of mental disorder at any given time. (Passer and Smith, 2004) Schizophrenia is one of the most serious of these mental disorders, and there are many different kinds of treatment. While all mental disorders offer diagnosis and treatment challenges, few are more challenging than schizophrenia. It is both bizarre and puzzling, and has been described as “one of the most challenging disorders to treat effectively.” (Passer and Smith, 2004, 534)

However, the results of many clinical trials promulgate its inefficacy and unreliability, with high relapse rates and a dependence on therapist competence.13

A 2010 study tested the effectiveness of a new FDA approved atypical antipsychotic medication Lurasidone. The researchers performed four six week clinical trials to test the